| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/13/2009 | US20090203105 URA5 gene and methods for stable genetic integration in yeast |
| 08/13/2009 | US20090203087 Expression of Granular Starch Hydrolyzing Enzymes in Trichoderma and process for producing glucose from granular starch substrates |
| 08/13/2009 | US20090203081 Inducible expression vectors and methods of use thereof |
| 08/13/2009 | US20090203080 S-Adenosylmethionine Synthetase Mutants, the DNAs Encoding the Same and Uses of the Mutants |
| 08/13/2009 | US20090203071 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor |
| 08/13/2009 | US20090203055 Compositions and methods for RNA interference with sialidase expression and uses thereof |
| 08/13/2009 | US20090203049 Beta integrin gene and protein |
| 08/13/2009 | US20090203046 Methods for identifying purkinje cells using the corl2 gene as a target |
| 08/13/2009 | US20090203042 Novel bt toxin receptors from lepidopteran insects and methods of use |
| 08/13/2009 | US20090203041 Bmp4 inhibitors |
| 08/13/2009 | US20090203038 Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays |
| 08/13/2009 | US20090203037 Anti-T. Cruzi Antibodies and Methods of Use |
| 08/13/2009 | US20090203035 Fluorescent proteins with increased photostability |
| 08/13/2009 | US20090203028 Novel aptamers that bind to listeria surface proteins |
| 08/13/2009 | US20090203026 Methods and compositions for targeting secretory lysosomes |
| 08/13/2009 | US20090203025 Branched and multi-chain nucleic acid switches for sensing and screening |
| 08/13/2009 | US20090203021 Detection of Clostridium difficile |
| 08/13/2009 | US20090203020 Bovine polymorphisms and methods of predicting bovine traits |
| 08/13/2009 | US20090203016 Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| 08/13/2009 | US20090203011 Methods and nucleic acids for analyses of cell proliferative disorders |
| 08/13/2009 | US20090203010 MSMB-gene based diagnosis, staging and prognosis of prostate cancer |
| 08/13/2009 | US20090203003 Inhibition of metallo-beta-lactamase |
| 08/13/2009 | US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer |
| 08/13/2009 | US20090202987 Canis sphingosine 1-phosphate receptor isoform 2 |
| 08/13/2009 | US20090202979 Production of antibody formats and immunological applications of said formats |
| 08/13/2009 | US20090202703 Fad-2 mutants and high oleic plants |
| 08/13/2009 | US20090202623 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 08/13/2009 | US20090202593 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/13/2009 | US20090202588 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202569 Prophylactic/Therapeutic Agent for Cancer |
| 08/13/2009 | US20090202568 Binding members for interleukin-4 receptor alpha (IL-4Ra)-173 |
| 08/13/2009 | US20090202559 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 08/13/2009 | US20090202558 TNFalpha-NEUTRALIZING ANTIBODIES |
| 08/13/2009 | US20090202556 Anti-claudin-4 antibody |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses |
| 08/13/2009 | US20090202544 Methods of Treating Diseases by Targeting Silt3 |
| 08/13/2009 | US20090202543 Gene and polypeptide relating to breast cancer |
| 08/13/2009 | US20090202537 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 08/13/2009 | US20090202532 High Functional Bispecific Antibody |
| 08/13/2009 | US20090202507 Intelligent Nanomedicine Integrating Diagnosis And Therapy |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202474 Expression of orphan gpr64 in inflammatory diseases |
| 08/13/2009 | US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090202429 Methods for testing anti-thrombotic agents |
| 08/13/2009 | DE102008008193A1 Roller- or plain bearing forgery-proof marking of a valuable document, comprises a bearing body with a surface, and a marking that enables a clear identification of the bearing body and comprises a synthetic nucleic acid |
| 08/13/2009 | CA2714630A1 Cis reactive oxygen quenchers integrated into linkers |
| 08/13/2009 | CA2714410A1 Disease markers and uses thereof |
| 08/13/2009 | CA2713156A1 Methods of diagnosing and treating parp-mediated diseases |
| 08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 08/12/2009 | EP2087139A2 Gene expression profiling based identification of genomic signatures of high-risk multiple myeloma and uses thereof |
| 08/12/2009 | EP2087129A2 Method for identifying modulators of the nrf2-keap1-are pathway |
| 08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
| 08/12/2009 | EP2086590A2 Modulation of t cell signaling threshold and t cell sensitivity to antigens |
| 08/12/2009 | EP2086528A2 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases |
| 08/12/2009 | EP1799857A4 Detection of cancer cells in body fluids |
| 08/12/2009 | EP1784503A4 Urine markers for detection of bladder cancer |
| 08/12/2009 | EP1687323A4 Methods and compositions for seamless cloning of nucleic acid molecules |
| 08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
| 08/12/2009 | EP1424895B1 Method for expression of small antiviral rna molecules within a cell |
| 08/12/2009 | EP1198589B9 Tenascin-c nucleic acid ligands |
| 08/12/2009 | EP1141239B1 Improved methods for insertion of nucleic acids into circular vectors |
| 08/12/2009 | CN101506384A Specialized oligonucleotides and their use in nucleic acid amplification and detection |
| 08/12/2009 | CN101506378A Single-molecule PCR on microparticles in water-in-oil emulsions |
| 08/12/2009 | CN101506368A Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 08/12/2009 | CN101506367A DNA molecules and methods |
| 08/12/2009 | CN101506227A OB-fold domains |
| 08/12/2009 | CN101505780A Treatment of development-related disorders |
| 08/12/2009 | CN101503453A Nucleic acid molecule CRYL1SI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503452A Nucleic acid molecule CRYL1SI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503451A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503450A Nucleic acid molecule CXSI3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503449A Nucleic acid molecule CXSI32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503448A Nucleic acid molecule CXSI22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503447A Nucleic acid molecule CXSI2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503446A Nucleic acid molecule CXSI1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503445A Nucleic acid molecule SI-CYPJ-32 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503444A Nucleic acid molecule SI-CYPJ-3 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503443A Nucleic acid molecule SI-CYPJ-22 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503442A Nucleic acid molecule SI-CYPJ-2 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503441A Nucleic acid molecule SI-CYPJ-1 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503440A Nucleic acid molecule SI-CYPJ-12 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503439A Nucleic acid molecule SI-CYPJ-52 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503438A Nucleic acid molecule SI-CYPJ-5 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503437A Nucleic acid molecule SI-CYPJ-4 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN101503436A Nucleic acid molecule SI-CYPJ-42 and use thereof in anti-cancer medicine preparation |
| 08/12/2009 | CN100526461C Method for obtaining plant introne sequence amplification polymorphism and its special primer |
| 08/12/2009 | CN100526331C CTL epitopes from EBV |
| 08/11/2009 | US7572963 Maize variety PHNWJ |
| 08/11/2009 | US7572952 Genetic construct with a coding sequence for a gamma -tocopherol methyltransferase operably connected to a plant promoter not natively associated with the coding sequence which when expressed in a plant results in an alteration in the ratio of alpha- gamma tocopherol |
| 08/11/2009 | US7572908 Cleaving a polynucleotide from a substrate in compositions having a polynucleotide bound to a substrate via a cleavable linker by contact with an alpha -effect nucleophile |
| 08/11/2009 | US7572907 Methods and compounds for polynucleotide synthesis |
| 08/11/2009 | US7572906 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 08/11/2009 | US7572905 Apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression |
| 08/11/2009 | US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
| 08/11/2009 | US7572903 Method of regulation of bacterial persister status |
| 08/11/2009 | US7572902 Expressed Sequence Tags (ESTs) isolated from maize useful in isolating genes and promoters, identifying and mapping the genes involved in developmental and metabolic pathways, and determining gene function |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |